Back
Range Cancer Therapeutics ETF Vs. Mercury Systems Industry Stock Comparison
Buy
63
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.58
Seasonality Move:
8.86%
Sell
48
MRCY
Mercury Systems
Last Price:
41.96
Seasonality Move:
7.56%
Buy
63
Range Cancer Therapeutics ETF (CNCR)
is a Buy
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $15.80. The Score for CNCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- CNCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Mercury Systems (MRCY)
is a Sell
Is Mercury Systems a Buy, Sell or Hold?
- The current Mercury Systems [MRCY] share price is $42.23. The Score for MRCY is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- MRCY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $15.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing slight selling pressure.
MRCY Stock Price Chart
What is Mercury Systems's stock price today?
-
The Mercury Systems share price today is $42.23
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRCY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 61.86 | Buy |
| Chaikin Money Flow: | -736 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.64 - 15.32) | Buy |
| Bollinger Bands (100): | (14.01 - 15.41) | Buy |
MRCY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 76.86 | Buy |
| Chaikin Money Flow: | 877819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.1 | Buy |
| 20-day SMA: | 15.08 | Buy |
| 50-day SMA: | 15.03 | Buy |
| 200-day SMA: | 15.07 | Buy |
| 8-day EMA: | 15.25 | Buy |
| 20-day EMA: | 15.09 | Buy |
| 50-day EMA: | 14.98 | Buy |
| 200-day EMA: | 14.6 | Buy |
MRCY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.48 | Buy |
| 20-day SMA: | 34.74 | Buy |
| 50-day SMA: | 36.05 | Buy |
| 200-day SMA: | 31.96 | Buy |
| 8-day EMA: | 35.51 | Buy |
| 20-day EMA: | 35.08 | Buy |
| 50-day EMA: | 35.33 | Buy |
| 200-day EMA: | 34.17 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Mercury Systems Earnings Growth & MRCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.38 per share, and an increase next year of $1.20 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Mercury Systems Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||